Dividend26 May 2026, 01:36 pm
Marksans Pharma Recommends ₹0.90 Dividend
AI Summary
Marksans Pharma Ltd's Board has recommended a final dividend of ₹0.90 per equity share (90% of face value of Re. 1) for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting (AGM). If approved, the dividend will be credited/dispatched within 30 days from the AGM date. The Board meeting was held on May 26, 2026, where the audited financial results for the quarter and year ended March 31, 2026, were also approved.
Key Highlights
- Marksans Pharma recommends a final dividend of ₹0.90 per share.
- Dividend is subject to shareholder approval at the AGM.
- Dividend payout will occur within 30 days of AGM approval.
- Audited financial results for FY26 were approved at the board meeting.
Price Impact
More from MARKSANS